Eli Lilly's new weight-loss pill, sold under the name Foundayo, gives consumers a second option for a non-injectable GLP-1.

At the heart of the request is whether taking Foundayo - made with a new active ingredient called orforglipron - could be ...

A recent FDA approval means consumers now have two GLP-1 weight loss pills to choose from as an alternative to the ...

The Food and Drug Administration is asking Eli Lilly to gather more safety data on its new weight loss pill, Foundayo, ...

Eli Lilly just released results of a clinical trial that may ease concerns about the safety of its new weight-loss pill ...

A doctor discusses common issues and questions around Foundayo, the oral obesity pill approved by the FDA this week.

People on Foundayo, the new GLP-1 weight loss pill from Eli Lilly, tend to feel full faster, and may experience nausea, constipation, or diarrhea.

Amazon will offer delivery of Eli Lilly's new weight-loss pill Foundayo and stock it at kiosks at some of the company's ...

The FDA also asked Lilly to conduct a milk-only lactation study in women who have received a dose to assess concentrations of ...

Americans starting weight-loss medicines for the first time want lower cost and greater convenience as they consider pills ...

Eli Lilly and Co. announced Thursday that its new weight-loss pill is now available in retail pharmacies in the United States ...

Korea’s biotech sector is churning out new fortunes as Big Pharma closes in with lucrative deals for everything from ...